Research Highlight | Published:

Immunotherapy: Viral reprogramming

Nature Reviews Cancer volume 18, page 135 (2018) | Download Citation

  • Subscribe to Nature Reviews Cancer for full access:

    $265

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    et al. Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. Sci. Transl Med. 10, eaao1641 (2018)

  2. 2.

    et al. Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Sci. Transl Med. 10, eaam7577 (2018)

Download references

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrc.2018.12

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

Authors

  1. Search for Anna Dart in: